Metronidazol Dak

Metronidazole, the active ingredient in Metronidazol Dak, is a nitroimidazole antibiotic presented as an oral tablet for oral use. It treats a range of anaerobic bacterial and protozoal infections in adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Metronidazol Dak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazol Dak is a nitroimidazole that targets anaerobic bacteria and susceptible protozoa across several infection types.

- Bacterial vaginosis: eradicates the anaerobic flora responsible for the condition. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing recurrence. - Amoebiasis: destroys Entamoeba histolytica trophozoites in intestinal disease. - Anaerobic bacterial infections: treats intra‑abdominal, pelvic, skin and soft‑tissue infections caused by obligate anaerobes. - Clostridioides difficile infection: reduces toxin‑producing bacteria and helps restore gut flora balance.

Metronidazol Dak may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Metallic taste: transient alteration of taste perception. - Headache: mild, often resolves without intervention. - Diarrhea: loose stools that usually improve with continued therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate medical attention. - Peripheral neuropathy: tingling or numbness in extremities, potentially irreversible. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatotoxicity: elevated liver enzymes indicating liver stress. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Before prescribing Metronidazol Dak, clinicians should consider several safety factors.

- Pregnancy: consult a healthcare provider as safety data are limited, especially in the first trimester. - Breastfeeding: evaluate risk versus benefit because the drug is excreted in milk. - Liver disease: adjust therapy if hepatic impairment is present. - Alcohol consumption: advise patients to avoid alcohol due to a disulfiram‑like reaction. - Neurologic disorders: monitor for signs of peripheral neuropathy or seizures. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Metronidazol Dak can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Disulfiram: concurrent use may cause severe flushing, tachycardia, and hypotension. - Warfarin: increased anticoagulant effect, requiring close INR monitoring.

Moderate Interactions (Monitor Closely): - Lithium: may raise serum lithium levels, necessitating periodic checks. - Cimetidine: can raise metronidazole plasma concentrations, watch for toxicity. - Alcohol-containing products: risk of a disulfiram‑like reaction; advise abstinence during therapy.